222 related articles for article (PubMed ID: 37198153)
1. ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patients.
Sachsenweger J; Jansche R; Merk T; Heitmeir B; Deniz M; Faust U; Roggia C; Tzschach A; Schroeder C; Riess A; Pospiech H; Peltoketo H; Pylkäs K; Winqvist R; Wiesmüller L
Cell Death Dis; 2023 May; 14(5):328. PubMed ID: 37198153
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrier cells.
Bose M; Sachsenweger J; Laurila N; Parplys AC; Willmann J; Jungwirth J; Groth M; Rapakko K; Nieminen P; Friedl TWP; Heiserich L; Meyer F; Tuppurainen H; Peltoketo H; Nevanlinna H; Pylkäs K; Borgmann K; Wiesmüller L; Winqvist R; Pospiech H
Hum Mol Genet; 2019 Dec; 28(24):4148-4160. PubMed ID: 31630195
[TBL] [Abstract][Full Text] [Related]
4. Genetic steps of mammalian homologous repair with distinct mutagenic consequences.
Stark JM; Pierce AJ; Oh J; Pastink A; Jasin M
Mol Cell Biol; 2004 Nov; 24(21):9305-16. PubMed ID: 15485900
[TBL] [Abstract][Full Text] [Related]
5. Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides
Voutsadakis IA; Stravodimou A
Anticancer Res; 2023 Mar; 43(3):967-981. PubMed ID: 36854505
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.
Obermeier K; Sachsenweger J; Friedl TW; Pospiech H; Winqvist R; Wiesmüller L
Oncogene; 2016 Jul; 35(29):3796-806. PubMed ID: 26640152
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk of DNA double-strand break repair pathways in poly(ADP-ribose) polymerase inhibitor treatment of breast cancer susceptibility gene 1/2-mutated cancer.
Sunada S; Nakanishi A; Miki Y
Cancer Sci; 2018 Apr; 109(4):893-899. PubMed ID: 29427345
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.
Fridlich R; Annamalai D; Roy R; Bernheim G; Powell SN
DNA Repair (Amst); 2015 Jun; 30():11-20. PubMed ID: 25836596
[TBL] [Abstract][Full Text] [Related]
10. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
[TBL] [Abstract][Full Text] [Related]
11. The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations.
Adamson AW; Ding YC; Mendez-Dorantes C; Bailis AM; Stark JM; Neuhausen SL
Mol Oncol; 2020 Jun; 14(6):1124-1133. PubMed ID: 32175645
[TBL] [Abstract][Full Text] [Related]
12. BRCA gene structure and function in tumor suppression: a repair-centric perspective.
Murphy CG; Moynahan ME
Cancer J; 2010; 16(1):39-47. PubMed ID: 20164689
[TBL] [Abstract][Full Text] [Related]
13. PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
Sy SM; Huen MS; Chen J
Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7155-60. PubMed ID: 19369211
[TBL] [Abstract][Full Text] [Related]
14. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
[TBL] [Abstract][Full Text] [Related]
15. Single-Strand Annealing in Cancer.
Blasiak J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671579
[TBL] [Abstract][Full Text] [Related]
16. [BRCA1 and BRCA2 - pathologists starting kit].
Škapa P
Cesk Patol; 2016; 52(4):193-196. PubMed ID: 27869444
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.
Thompson EG; Fares H; Dixon K
Environ Mol Mutagen; 2012 Jan; 53(1):32-43. PubMed ID: 22170030
[TBL] [Abstract][Full Text] [Related]
18. DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers.
Vaclová T; Gómez-López G; Setién F; Bueno JM; Macías JA; Barroso A; Urioste M; Esteller M; Benítez J; Osorio A
Breast Cancer Res Treat; 2015 Jul; 152(2):271-82. PubMed ID: 26071757
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting and patient selection for cancers with homologous recombination defects.
Talens F; Jalving M; Gietema JA; Van Vugt MA
Expert Opin Drug Discov; 2017 Jun; 12(6):565-581. PubMed ID: 28425306
[TBL] [Abstract][Full Text] [Related]
20. BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer.
Pothuri B
Ann Oncol; 2013 Nov; 24 Suppl 8():viii22-viii27. PubMed ID: 24131965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]